178 related articles for article (PubMed ID: 12884907)
1. Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets.
Barnes CJ; Kumar R
Cancer Metastasis Rev; 2003 Dec; 22(4):301-7. PubMed ID: 12884907
[TBL] [Abstract][Full Text] [Related]
2. Targeting the HER-kinase axis in cancer.
Gross ME; Shazer RL; Agus DB
Semin Oncol; 2004 Feb; 31(1 Suppl 3):9-20. PubMed ID: 15052539
[TBL] [Abstract][Full Text] [Related]
3. The ErbB receptors and their ligands in cancer: an overview.
Normanno N; Bianco C; Strizzi L; Mancino M; Maiello MR; De Luca A; Caponigro F; Salomon DS
Curr Drug Targets; 2005 May; 6(3):243-57. PubMed ID: 15857286
[TBL] [Abstract][Full Text] [Related]
4. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
5. [Targeting of membrane receptor tyrosine kinases: is there resistance in the HER?].
Monnier L; Milano G; Penault-Llorca F; Merlin JL
Bull Cancer; 2004 Sep; 91(9):685-94. PubMed ID: 15544994
[TBL] [Abstract][Full Text] [Related]
6. The HER family and cancer: emerging molecular mechanisms and therapeutic targets.
Sergina NV; Moasser MM
Trends Mol Med; 2007 Dec; 13(12):527-34. PubMed ID: 17981505
[TBL] [Abstract][Full Text] [Related]
7. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.
Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF
J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
9. Roles for neuregulins in human cancer.
Stove C; Bracke M
Clin Exp Metastasis; 2004; 21(8):665-84. PubMed ID: 16035612
[TBL] [Abstract][Full Text] [Related]
10. Targeting ErbB receptor signaling: a pan-ErbB approach to cancer.
Britten CD
Mol Cancer Ther; 2004 Oct; 3(10):1335-42. PubMed ID: 15486201
[TBL] [Abstract][Full Text] [Related]
11. Biology of the epidermal growth factor receptor family.
Barnes CJ; Kumar R
Cancer Treat Res; 2004; 119():1-13. PubMed ID: 15164870
[No Abstract] [Full Text] [Related]
12. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials.
Voldborg BR; Damstrup L; Spang-Thomsen M; Poulsen HS
Ann Oncol; 1997 Dec; 8(12):1197-206. PubMed ID: 9496384
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
14. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
15. The epidermal growth factor receptor family: biology driving targeted therapeutics.
Wieduwilt MJ; Moasser MM
Cell Mol Life Sci; 2008 May; 65(10):1566-84. PubMed ID: 18259690
[TBL] [Abstract][Full Text] [Related]
16. Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature.
Pietras RJ
Breast J; 2003; 9(5):361-73. PubMed ID: 12968955
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases.
Stern DF
Breast Cancer Res; 2000; 2(3):176-83. PubMed ID: 11250707
[TBL] [Abstract][Full Text] [Related]
18. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.
Yarden Y
Eur J Cancer; 2001 Sep; 37 Suppl 4():S3-8. PubMed ID: 11597398
[TBL] [Abstract][Full Text] [Related]
19. Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target.
Chu PY; Tai YL; Shen TL
Cells; 2019 May; 8(5):. PubMed ID: 31083325
[TBL] [Abstract][Full Text] [Related]
20. Emerging therapies in gastrointestinal cancers.
Nautiyal J; Rishi AK; Majumdar AP
World J Gastroenterol; 2006 Dec; 12(46):7440-50. PubMed ID: 17167831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
